Want to join the conversation?
$EMR 3Q15 PR: Net sales were $5,503MM, down 13% vs. $6,312MM in 3Q14. Underlying sales were down 5% excluding unfavorable currency translation of 5% and an impact from divestitures of 3%. Net earnings were $564MM or $0.84 per diluted share vs. $728MM or $1.03 per diluted share in 3Q14.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.